Today: 2 February 2026
Subscribe
Browse Category

Biotechnology News 22 January 2026 - 23 January 2026

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

Gilead stock jumps again as Trodelvy-Keytruda breast cancer data hit NEJM

New York, Jan 23, 2026, 15:38 EST — Regular session Gilead Sciences shares climbed $4.59, or 3.5%, to $135.73 in Friday afternoon trading, building on a strong two-day surge and hitting new highs. The stock started the day at $131.26 and fluctuated between $130.65 and $136.26, with roughly 8.8 million shares traded. This week, Gilead updated investors after The New…
23 January 2026
·······
Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

New York, Jan 23, 2026, 08:55 EST — Premarket Revelation Biosciences shares climbed roughly 2% in premarket Friday, adding to a rollercoaster week for the lightly traded biotech. Investors were reacting to the company’s newest regulatory update. The stock last changed hands near $0.85. This move is crucial as the company aims to consolidate early-stage research into one late-stage trial,…
23 January 2026
·····
CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

New York, Jan 23, 2026, 05:47 (EST) — Premarket CRISPR Therapeutics AG shares slipped about 0.5% to $60.51 in premarket trading on Friday, following a sharp 11.1% gain the previous day. The stock closed at $60.81 on Thursday after hitting an intraday high of $60.86 and seeing over 3.4 million shares change hands. Investors were reacting to an insider-sale filing.…
23 January 2026
····
Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

New York, Jan 23, 2026, 05:30 EST — Premarket Regencell Bioscience Holdings Ltd shares climbed 16.3% to $35.77 in premarket trading Friday, building on a steep rise from the day before. (StockAnalysis) That’s important since premarket trading—before the 9:30 a.m. ET open—can amplify price swings, particularly in stocks that are already volatile during regular sessions. The stock jumped 40.4% on…
23 January 2026
····
CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

CSL share price rises on ASX as U.S. vaccine policy shifts rattle the sector

Sydney, Jan 23, 2026, 16:51 AEDT — After-hours CSL Ltd shares (CSL.AX) closed Friday 0.7% higher at A$179.62, building on Thursday’s 1.3% rise. The stock fluctuated between A$179.33 and A$180.80 during the session, with roughly 1.01 million shares traded. (Investing) The upward drift follows increased scrutiny on vaccine makers after broad U.S. policy shifts under Health Secretary Robert F. Kennedy…
23 January 2026
····
Moderna (MRNA) stock jumps after-hours as CEO signals pullback in new vaccine trials

Moderna (MRNA) stock jumps after-hours as CEO signals pullback in new vaccine trials

New York, January 22, 2026, 18:46 EST — After-hours Moderna shares surged 4.2% to $51.87 in after-hours trading Thursday, following an earlier jump of about 11% to $55.17 on heavy volume—more than 34 million shares changed hands. CEO Stephane Bancel told Bloomberg TV the company won’t invest in new late-stage (Phase 3) vaccine trials, pointing to growing resistance from U.S.…
23 January 2026
····
GRAIL stock jumps as Galleri outlook and FDA filing timeline come back into focus

GRAIL stock jumps as Galleri outlook and FDA filing timeline come back into focus

New York, Jan 22, 2026, 15:23 EST — Regular session Shares of GRAIL (GRAL.O) surged 13.2% to $114.41 Thursday afternoon, topping out at an intraday high of $118.50 earlier in the session. (Yahoo Finance) This shift is critical now since GRAIL is at a point where minor shifts in adoption and cash flow can rapidly alter forecasts. The company markets…
22 January 2026
···
Thermo Fisher stock price today: TMO steadies near a 52-week high ahead of Jan. 29 earnings

Thermo Fisher stock price today: TMO steadies near a 52-week high ahead of Jan. 29 earnings

New York, Jan 22, 2026, 13:34 (EST) — Regular session Thermo Fisher Scientific Inc (TMO) shares rose $2.03, or 0.3%, to $638.33 on Thursday afternoon, after briefly climbing as high as $643.66 earlier in the session. The stock is hovering near its best levels in a year as investors line up ahead of the company’s fourth-quarter and full-year 2025 results,…
22 January 2026
·····
Regencell Bioscience (RGC) stock price jumps 37% again as the latest swing hits Nasdaq screens

Regencell Bioscience (RGC) stock price jumps 37% again as the latest swing hits Nasdaq screens

New York, Jan 22, 2026, 13:19 EST — Regular session Shares of Regencell Bioscience Holdings Limited jumped roughly 37% to $29.98 in afternoon trading Thursday, rebounding sharply from earlier dips. The stock swung between $20.91 and $30.78, with around 1 million shares changing hands by 1:19 p.m. EST. This move stands out because it follows a sharp drop in the…
22 January 2026
·····
Moderna stock jumps again as Merck cancer vaccine data keeps MRNA rally running

Moderna stock jumps again as Merck cancer vaccine data keeps MRNA rally running

New York, Jan 22, 2026, 10:15 EST — Regular session Moderna shares climbed 7.7% to $53.65 Thursday morning, extending gains fueled by fresh long-term data on its experimental personalized cancer vaccine, created in partnership with Merck. Moderna’s push is vital as it aims to convince investors it can thrive beyond COVID vaccines. A promising mid-stage oncology trial could swiftly shift…
22 January 2026
····
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

New York, Jan 22, 2026, 05:11 EST — Premarket Vertex Pharmaceuticals (VRTX) shares jumped 4.31%, closing Wednesday at $461.14 and marking their third straight session of gains. Trading volume climbed past the stock’s 50-day average. VRTX outperformed peers like AbbVie, Krystal Biotech, and Arcturus Therapeutics, while the S&P 500 and Dow each gained over 1%. (MarketWatch) Vertex is now under…
22 January 2026
·····
Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data

Moderna stock (MRNA) steadies in premarket after 16% surge on Merck cancer-vaccine data

New York, Jan 22, 2026, 04:51 EST — Premarket. Moderna shares were flat at $49.81 in premarket trading on Thursday, after the stock jumped 15.8% in the previous session. (Yahoo Finance) The rally followed fresh five-year follow-up data on Moderna’s experimental personalised cancer vaccine used with Merck’s blockbuster immunotherapy Keytruda in high-risk melanoma, the companies said. (Merck) The move matters…
22 January 2026
······
1 2 3 4 … 24

Stock Market Today

  • Jardine Matheson Holdings Repurchases 100,700 Shares at Average Price of $73.64
    February 2, 2026, 7:02 AM EST. Jardine Matheson Holdings Ltd (JMH) repurchased 100,700 of its ordinary shares on February 2, 2026. The shares were bought back at prices ranging from $73.465 to $73.7327 per share, with a weighted average price of $73.6397. Following cancellation of these shares, JMH's issued share capital now stands at 294,404,878 ordinary shares, each with one voting right. JMH holds no treasury shares. This transaction reflects JMH's ongoing capital management strategy and complies with the Financial Conduct Authority's Disclosure Guidance and Transparency Rules. The share buyback reduces the total shares outstanding, potentially impacting shareholder value and voting power.
Go toTop